Daiichi Sankyo (ADR) News

Analysts Conflicted on These Healthcare Names: Daiichi Sankyo Company (OtherDSKYF), Inovio Pharmaceuticals (INO) and Molina Healthcare (MOH)

TipRanksJul 15 08:17 ET

Jefferies Adjusts Daiichi Sankyo's Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy

MT NewswiresMay 24 06:00 ET

Jefferies Adjusts Daiichi Sankyo's Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy

MT NewswiresFeb 21 04:27 ET

Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen

MT NewswiresDec 4, 2023 04:49 ET

Jefferies Adjusts Daiichi Sankyo's Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold

MT NewswiresOct 23, 2023 06:21 ET

Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen

MT NewswiresSep 25, 2023 06:11 ET

Esperion Jumps 15% as BofA Double-upgrades Citing Near-term Upside

Seeking AlphaJun 15, 2023 09:12 ET

Esperion Extends Selloff as Daiichi Sankyo Dispute Prompts BofA Downgrade

Seeking AlphaMar 16, 2023 09:13 ET

Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy

MT NewswiresDec 14, 2022 05:10 ET

Gilead Upgraded to Equal Weight at Barclays on Strong Execution in HIV, Kite

Seeking AlphaOct 31, 2022 10:20 ET

With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma

Benzinga Real-time NewsSep 21, 2022 14:21 ET